In addition, genetic studies of risk-modifiers focused in the BRCA1 and BRCA2 genes have identified 26 and 16 SNPs associated with BC risk in BRCA1/2 mutation carriers, which have small associated effect sizes (1.05–1.26) per copy of the minor allele [10,33,34]. This evidence concerns the gene BRCA2 and breast cancer.